High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
- Citation:
- Blood Cancer J vol 7 (6) e576-
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 6
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA025224, U10CA180790, U10 CA180821, U10 CA180882
- Corr. Author:
- Authors:
- T E Witzig B LaPlant T M Habermann E McPhail D J Inwards I N Micallef J P Colgan G S Nowakowski S M Ansell P B Johnston
- Networks:
- LAPS-MN026
- Study
- NCCTG-N1085
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- Letter to the Editor